Recombinant Human Melanoma-associated antigen 3 (MAGEA3)

Cat# MBS961973-0,02mg-E

Size : 0.02mg(E-Coli)

Brand : MyBiosource

Contact local distributor :


Phone : +1 850 650 7790
Recombinant Human Melanoma-associated antigen 3 (MAGEA3)

Melanoma-Associated Antigen 3 (MAGEA3) Human Recombinant Protein

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS961973

This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this… More details

Product Overview

Online Datasheet in PDF
Product Name
Melanoma-associated antigen 3 (MAGEA3), Recombinant Protein
Full Product Name
Recombinant Human Melanoma-associated antigen 3 (MAGEA3)
Product Gene Name
MAGEA3 recombinant protein
Sequence
MPLEQRSQHC KPEEGLEARG EALGLVGAQA PATEEQEAAS SSSTLVEVTL GEVPAAESPD PPQSPQGASS LPTTMNYPLW SQSYEDSSNQ EEEGPSTFPD LESEFQAALS RKVAELVHFL LLKYRAREPV TKAEMLGSVV GNWQYFFPVI FSKASSSLQL VFGIELMEVD PIGHLYIFAT CLGLSYDGLL GDNQIMPKAG LLIIVLAIIA REGDCAPEEK IWEELSVLEV FEGREDSILG DPKKLLTQHF VQENYLEYRQ VPGSDPACYE FLWGPRALVE TSYVKVLHHM VKISGGPHIS YPPLHEWVLR EGEE
Host
E Coli or Yeast or Baculovirus or Mammalian Cell
Form/Format
Lyophilized or liquid (Format to be determined during the manufacturing process)
Purity/Purification
Greater or equal to 85% purity as determined by SDS-PAGE. (lot specific)
Preparation and Storage
Store at -20 degrees C. For long-term storage, store at -20 degrees C or -80 degrees C. Store working aliquots at 4 degrees C for up to one week. Repeated freezing and thawing is not recommended.
Molecular Weight
39.8 kDa
Sequence Positions
1-314. Full Length
Tag Information
This protein contains an N-terminal tag and may also contain a C-terminal tag. Tag types are determined by various factors including tag-protein stability, please inquire for tag information.
Sterility
Sterile filter available upon request.
Endotoxin
Low endotoxin available upon request.
OMIM
300174
3D Structure
ModBase 3D Structure for P43357
Species
Human
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.

Other Notes

Small volumes of MAGEA3 recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for MAGEA3 purchase

MBS961973 is a recombinant protein targeting MAGEA3. Also known as Recombinant Human Melanoma-associated antigen 3 (MAGEA3). Host: E Coli or Yeast or Baculovirus or Mammalian Cell.

Additional Details

NCBI/Uniprot data below describe general gene information for MAGEA3. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
melanoma-associated antigen 3
NCBI Official Synonym Full Names
MAGE family member A3
NCBI Official Symbol
MAGEA3
NCBI Official Synonym Symbols
HIP8; HYPD; CT1.3; MAGE3; MAGEA6
UniProt Protein Name
Melanoma-associated antigen 3
UniProt Synonym Protein Names
Antigen MZ2-D; Cancer/testis antigen 1.3; CT1.3; MAGE-3 antigen
Protein Family
Melanoma-associated antigen
UniProt Gene Name
MAGEA3
UniProt Synonym Gene Names
MAGE3; CT1.3
NCBI Protein Information
melanoma-associated antigen 3

UniProt Comments for MAGEA3

Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with MAGEA3 recombinant protein

 Reference Product  PubMed Publications
 HLA-A recombinant protein  >94 publications with MAGEA3 and HLA-A
 MLANA recombinant protein  >56 publications with MAGEA3 and MLANA
 GAGE2A recombinant protein  >9 publications with MAGEA3 and GAGE2A
 TRIM28 recombinant protein  >2 publications with MAGEA3 and TRIM28
 SILV recombinant protein  >1 publications with MAGEA3 and SILV
 BAGE2 recombinant protein  >1 publications with MAGEA3 and BAGE2

Diseases associated with MAGEA3 recombinant protein

 Disease Name  Pubmed Publications
 Melanoma Antibodies  >323 publications with MAGEA3 and Melanoma
 Carcinoma Antibodies  >138 publications with MAGEA3 and Carcinoma
 Neoplasm Metastasis Antibodies  >76 publications with MAGEA3 and Neoplasm Metastasis
 Lung Neoplasms Antibodies  >56 publications with MAGEA3 and Lung Neoplasms
 Lung Diseases Antibodies  >55 publications with MAGEA3 and Lung Diseases
 Adenocarcinoma Antibodies  >51 publications with MAGEA3 and Adenocarcinoma
 Head and Neck Neoplasms Antibodies  >42 publications with MAGEA3 and Head and Neck Neoplasms
 Carcinoma, Squamous Cell Antibodies  >37 publications with MAGEA3 and Carcinoma, Squamous Cell
 Carcinoma, Non-Small-Cell Lung Antibodies  >34 publications with MAGEA3 and Carcinoma, Non-Small-Cell Lung
 Bronchial Neoplasms Antibodies  >32 publications with MAGEA3 and Bronchial Neoplasms

Organs/Tissues associated with MAGEA3 recombinant protein

 Organ/Tissue Name  Pubmed Publications
 Testis Antibodies  >112 publications with MAGEA3 and Testis
 Lung Antibodies  >61 publications with MAGEA3 and Lung
 Skin Antibodies  >55 publications with MAGEA3 and Skin
 Lymph Node Antibodies  >49 publications with MAGEA3 and Lymph Node
 Liver Antibodies  >33 publications with MAGEA3 and Liver
 Bone Antibodies  >14 publications with MAGEA3 and Bone
 Placenta Antibodies  >12 publications with MAGEA3 and Placenta
 Brain Antibodies  >11 publications with MAGEA3 and Brain
 Salivary Gland Antibodies  >3 publications with MAGEA3 and Salivary Gland
 Prostate Antibodies  >3 publications with MAGEA3 and Prostate